。。。。。-To The Moon - Tiger Brokers Online Investing Community - To The Moon

2
Comment
Favorite

小可爱555
2021-08-19

。。。。。

心玮医疗暗盘暴跌17% 公司前三个月亏损4130万元

心玮医疗暗盘暴跌17%，报价141.6港元，每手亏1470港元。截至2019年及2020年12月31日止年度以及截至2021年3月31日止三个月，总亏损净额分别为人民币75.5百万元、人民币216.2百万元及人民币41.3百万元。　　心玮医疗发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。

心玮医疗暗盘暴跌17% 公司前三个月亏损4130万元

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

2

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":838964398,"tweetId":"838964398","gmtCreate":1629366337614,"gmtModify":1676530017083,"author":{"id":3551007188710375,"authorId":3551007188710375,"authorIdStr":"3551007188710375","name":"小可爱555","avatar":"https://static.tigerbbs.com/e2c7ce2055908489c6a2935faedea93a","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>。。。。。</p></body></html>","htmlText":"<html><head></head><body><p>。。。。。</p></body></html>","text":"。。。。。","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/838964398","repostId":2160768545,"repostType":2,"repost":{"id":"2160768545","pubTimestamp":1629361663,"share":"https://www.laohu8.com/m/news/2160768545?lang=&edition=full","pubTime":"2021-08-19 16:27","market":"hk","language":"zh","title":"心玮医疗暗盘暴跌17% 公司前三个月亏损4130万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2160768545","media":"新浪港股","summary":"心玮医疗暗盘暴跌17%，报价141.6港元，每手亏1470港元。截至2019年及2020年12月31日止年度以及截至2021年3月31日止三个月，总亏损净额分别为人民币75.5百万元、人民币216.2百万元及人民币41.3百万元。　　心玮医疗发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。","content":"<html><body><div>\n<p>　　心玮医疗(06609.HK)暗盘暴跌17%，报价141.6港元，每手亏1470港元。</p>\n<div><img src=\"http://n.sinaimg.cn/finance/transform/140/w550h390/20210819/7d76-ecd7d1d67fd2e76103565afdf58f1d0d.png\"/><span></span></div>\n<p>　　心玮医疗成立于2016年，是一家创新型神经介入医疗器械公司，公司的营产品组合包括神经介入及心脏医疗器械，公司的两款核心产品分别是CaptorTM取栓器械（「Captor」）及左心耳封堵器，公司致力通过商业化在研产品，降低中国乃至全球的脑卒中死亡率并改善预后。</p>\n<p>　　公司于往绩记录期间各期间录得亏损净额。截至2019年及2020年12月31日止年度以及截至2021年3月31日止三个月，总亏损净额分别为人民币75.5百万元、人民币216.2百万元及人民币41.3百万元。</p>\n<p>　　心玮医疗发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。公开发售阶段<a href=\"https://laohu8.com/S/06609\">心玮医疗-B</a>获约333.14倍认购，分配至公开发售的发售股份最终数目为330.1万股，占发售股份总数的50%。合共接获235040份有效申请，一手中签率10%，认购200手稳中一手。</p>\n<div>\n<span>股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿&gt;&gt;</span>\n<img src=\"\"/>\n</div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量资讯、精准解读，尽在<a href=\"https://laohu8.com/S/SINA\">新浪</a>财经APP</div>\n</div>\n</div></body></html>","source":"highlight_sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>心玮医疗暗盘暴跌17% 公司前三个月亏损4130万元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n心玮医疗暗盘暴跌17% 公司前三个月亏损4130万元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-19 16:27 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggipo/2021-08-19/doc-ikqciyzm2404160.shtml><strong>新浪港股</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>心玮医疗(06609.HK)暗盘暴跌17%，报价141.6港元，每手亏1470港元。\n\n　　心玮医疗成立于2016年，是一家创新型神经介入医疗器械公司，公司的营产品组合包括神经介入及心脏医疗器械，公司的两款核心产品分别是CaptorTM取栓器械（「Captor」）及左心耳封堵器，公司致力通过商业化在研产品，降低中国乃至全球的脑卒中死亡率并改善预后。\n　　公司于往绩记录期间各期间录得亏损净额。截至...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggipo/2021-08-19/doc-ikqciyzm2404160.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/516cbe31098a2a42f16da93a5544fbb1","relate_stocks":{"06609":"心玮医疗-B"},"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2021-08-19/doc-ikqciyzm2404160.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2160768545","content_text":"心玮医疗(06609.HK)暗盘暴跌17%，报价141.6港元，每手亏1470港元。\n\n　　心玮医疗成立于2016年，是一家创新型神经介入医疗器械公司，公司的营产品组合包括神经介入及心脏医疗器械，公司的两款核心产品分别是CaptorTM取栓器械（「Captor」）及左心耳封堵器，公司致力通过商业化在研产品，降低中国乃至全球的脑卒中死亡率并改善预后。\n　　公司于往绩记录期间各期间录得亏损净额。截至2019年及2020年12月31日止年度以及截至2021年3月31日止三个月，总亏损净额分别为人民币75.5百万元、人民币216.2百万元及人民币41.3百万元。\n　　心玮医疗发布公告，公司发行约660.19万股股份，每股定价171港元，每手50股，预期8月20日上市。公开发售阶段心玮医疗-B获约333.14倍认购，分配至公开发售的发售股份最终数目为330.1万股，占发售股份总数的50%。合共接获235040份有效申请，一手中签率10%，认购200手稳中一手。\n\n股民福利！金牛、茅台、手机……任务“豪”礼，等你来拿>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","news_type":1},"isVote":1,"tweetType":1,"viewCount":184,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}